- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-18-0181716

About Axiommax Oncology Private Limited
Data last updated:
Axiommax Oncology Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the oncology clinics and cancer treatment segment of the healthcare sector. It was incorporated on 03 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2016PTC284390. Its GSTIN is 27AAOCA6496K1ZV (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Uttamchand Kesharimal Jain and Ashokkumar Keshrimal Jain.
Its last annual general meeting (AGM) was held on 22 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2026, the company reported a revenue of ₹15.3 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net loss of ₹3.69 Cr (net margin -24.1%) and EBITDA of -₹3.67 Cr (EBITDA margin -24%). Revenue has grown at a compounded annual rate (CAGR) of 14% over three years and 29% over five years.
The company has about 34 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Axiommax Oncology. Court records list 4 cases involving the company, including 4 filed by the company.
Axiommax Oncology Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0181716). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website axiommax.com.
Company details
Recognitions & Rankings of Axiommax Oncology
Contact details
Axiommax Oncology Private Limited's registered office is in Mumbai, Maharashtra. Its website is axiommax.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address146 Damji Shamji Industrial Complex 28 Mahal Indust. Estate Mahakali Caves Road And, Heri East, Mumbai, Maharashtra, India – 400093
- IndustryHealthcare, Oncology Clinics & Cancer Treatment
To see the full contact details of Axiommax Oncology Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Axiommax Oncology operates one associated brand: Axiommax Oncology. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Oncology therapies and healthcare services are delivered in the global industry. | axiommax.com |
Business activity
The main business activity of Axiommax Oncology is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Axiommax Oncology Private Limited, buy the company report.
Financials of Axiommax Oncology Private Limited
FY 2026 filings availableAxiommax Oncology Private Limited reported revenue of ₹15.3 Cr (up 2% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 29% over five years, including 2% growth in the latest year. EBITDA fell 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹15.3 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.67 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹3.69 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -24% | ||||
| Net Profit Margin | -24.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Axiommax Oncology Private Limited, buy the company report.
Board of directors of Axiommax Oncology Private Limited
Axiommax Oncology has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Uttamchand Kesharimal Jain Also directs: Neon Laboratories Limited, VHB Pharmaceuticals Private Limited, VHB Medi Sciences Limited and 5 more | Director | 03 Aug 2016 | 10 Years 3 Months | Current |
| Ashokkumar Keshrimal Jain Also directs: Neon Laboratories Limited, Surajlok Chemicals Private Limited, VHB Pharmaceuticals Private Limited and 3 more | Director | 03 Aug 2016 | 10 Years 3 Months | Current |
Auditor
Axiommax Oncology Private Limited is audited by Raju More & Associates for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Raju More & Associates | FY 2026 | 123003 |
Shareholding
The shareholding of Axiommax Oncology Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Axiommax Oncology Private Limited, buy the company report.
Legal cases
Axiommax Oncology Private Limited has 4 court cases on record: 4 filed by Axiommax Oncology. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 4 | 0 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (COMIP) | Filed by the company against Halsted Pharma Private Limited and 2 others | Disposed |
| Bombay High Court | Court case (LPETN) | Filed by the company against Halsted Pharma Private Limited | Disposed |
| Bombay High Court | Interim or miscellaneous application | Filed by the company against Halsted Pharma Private Limited and 1 other | Disposed |
| High Court, MAHARASHTRA | Court case (CRR) | Filed by the company against Halsted Pharma Private Limited and Anr. | Disposed |
To see the full case history of Axiommax Oncology Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Axiommax Oncology Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Axiommax Oncology Private Limited has a workforce of 34 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 34 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Axiommax Oncology Private Limited, buy the company report.
GST
Axiommax Oncology has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAOCA6496K1ZV | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Axiommax Oncology Private Limited, buy the company report.
Recent activity
Axiommax Oncology Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Ashokkumar Keshrimal Jain was appointed as Director on 03 Aug 2016.
Frequently asked questions
Axiommax Oncology is an active private limited company based in Mumbai, Maharashtra, India. The company works in oncology clinics and cancer treatment, within the healthcare industry. It was incorporated on 03 August 2016 (10+ years old) and is registered under CIN U24110MH2016PTC284390.
Axiommax Oncology has 2 current directors:
- Uttamchand Kesharimal Jain - Director
- Ashokkumar Keshrimal Jain - Director
The latest financial statements of Axiommax Oncology on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 22 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Axiommax Oncology is 27AAOCA6496K1ZV, registered in Maharashtra.
The CIN (Corporate Identification Number) of Axiommax Oncology is U24110MH2016PTC284390. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Axiommax Oncology has 4 court cases on record: 4 filed by the company.
Axiommax Oncology was incorporated on 03 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Ashokkumar Keshrimal Jain was appointed as Director on 03 Aug 2016. Uttamchand Kesharimal Jain was appointed as Director on 03 Aug 2016.
Yes, Axiommax Oncology is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0181716).
Axiommax Oncology can be reached through the website axiommax.com. Its registered office is in Mumbai, Maharashtra, India.

